Here are relevant reports on : atp-assay-market
-
Immunofluorescence Assay Market by Product (Reagent, Instruments, Antibodies, Kits, Consumables & Accessories), Type (Direct, Indirect), Disease (Infectious Disease, Other Diseases), End User (Contract Research Organizations) – Global Forecast to 2026
The immunofluorescence assays market is expected to grow from USD 2.6 billion in 2021 to USD 83.5 billion by 2026, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.Thermo Fisher Scientific Inc (US), Abcam PLC (UK), Bio-Rad Laboratories, Inc (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Werfen Company (Spain), Cell Signaling Technology, Inc. (US), MEDIPAN GmbH (Germany)
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End User (Pharma & Biotech) & Region - Global Forecasts to 2025
The global oxidative stress assay market growth is primed to transition from USD 836 million in 2020 to USD 1,326 million by 2025, showcasing a strong CAGR of 9.7%. Growth in the oxidative stress assay market is attributed to factors such as the biopharmaceutical industry and increasing public-sector funding for academic research.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030
Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
EliSpot and FluoroSpot Assay Market by Product (Assay kit (Technique, Utility, Analyte (T Cell and B Cell assay)), Analyzer), Application (Transplants, Infectious Diseases, Vaccine Development, Cancer Research), End User & Region - Global Forecast to 2028
The global EliSpot and FluoroSpot assay market, valued at US$272 million in 2022, stood at US$292 million in 2023 and is projected to advance at a resilient CAGR of 7.6% from 2023 to 2028, culminating in a forecasted valuation of US$421 million by the end of the period. The expansion of this market is majorly due to up surging cases of chronic diseases such as cancer as well as growing Growth in biotechnology and biopharmaceutical industries.
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Breast Biopsy Devices Market by Product (Needle: Core, FNAB, VAB; Equipment, Wire, Guidance system, Table, Assay kit), Procedure (Needle, Liquid: CTC, CTDNA; Open), Application (Screening, Monitoring), End User (Hospital, Clinic) - Global Forecasts to 2030
The global breast biopsy devices market, valued at US$2,255.0 million in 2024, stood at US$2,384.1 million in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$3,261.7 million by the end of the period. The breast biopsy devices market is driven by rising breast cancer incidence, growing awareness, technological advancements, and increased demand for minimally invasive procedures.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry), End User (Hospitals) & Region - Global Forecast to 2026
The global newborn screening market growth is primed to transition from $0.9 billion in 2021 to $1.3 billion by 2026, showcasing a strong CAGR of 8.3%. Growth in this market is primarily driven by the increasing prevalence of newborn disorders and favourable reimbursement policies. However, the availability of refurbished products is expected to restrain the growth of this market to a certain extent during the forecast period.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Alpha-Methylstyrene Market by Application(ABS, Para-Cumylphenol, Adhesives & Coatings, Waxes), Purity(Assay above 99.5% and Between 95% to 99.5%), Region(Asia Pacific, Europe, North America, Middle East & Africa, South America) - Global Forecast to 2024
The alpha-methylstyrene market is projected to grow from USD 473 million in 2019 to USD 543 million by 2024, at a CAGR of 2.8% from 2019 to 2024. Surging demand for Acrylonitrile Butadiene Styrene (ABS) from the automotive and electronic appliances industries is fueling the growth of the market across the globe. Increasing demand for consumer goods from emerging economies acts as an opportunity for the growth of the alpha-methylstyrene market, worldwide. INEOS Group Holding S.A. (Switzerland), AdvanSix (US), Rosneft (Russia), Altivia Corp. (US), SI Group Inc. (US), DOMO Chemicals (Belgium), Kumho P&B Chemicals (South Korea), Taiwan Prosperity Chemical Corp. (Taiwan), Yangzhou Lida Chemicals (China), Mitsubishi Chemical Corporation (Japan), Solvay SA (Belgium), and Mitsui Chemicals, Inc. (Japan) are some of the leading players operating in the alpha-methylstyrene market.
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Glycated Albumin Assay Market Size, Share & Trends by Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User (Hospitals & Diabetic Care Center, Diagnostic Laboratory) & Region (North America, Europe, APAC, Latin America, & MENA) - Global Forecast to 2028
The global glycated albumin assay market, valued at US$0.1 billion in 2022, stood at US$0.2 billion in 2023 and is projected to advance at a resilient CAGR of 8.9% from 2023 to 2028, culminating in a forecasted valuation of US$0.3 billion by the end of the period. Market growth is driven by the increased focus of the government on disease diagnosis, the high prevalence of diabetes, and increasing initiatives to spread awareness of diabetes diagnosis.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028
The global isothermal nucleic acid amplification technology market, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 9.2% from 2023 to 2028, culminating in a forecasted valuation of US$6.8 billion by the end of the period. The growth of the market is attributed to the cost-benefits of INAAT, rising prevalence of infectious diseases, and increasing number of blood transfusions and donations.
- Published: March 2023
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
